A pioneering medical device now being introduced across NHS hospitals in Scotland could save the health service millions of pounds each year and free up thousands of vital surgery slots, according to an independent economic analysis.
The report suggests that widespread adoption of the “miscarriage collection cradle” could result in annual savings of between £6.7 million and £11.2 million for the NHS. It is projected this would free up between 7,300 and 12,000 gynaecology surgery slots annually, with a separate analysis indicating a 50% adoption rate could also reduce Emergency Department admissions by 10,000 each year.
How a simple design changes care
The cradle, designed to fit beneath a standard toilet seat, offers a new option for women managing miscarriage. Developed by Dignity Care, its purpose is to provide a more dignified and controlled experience at home while also serving a critical clinical function. The kit includes a removable sieve to collect pregnancy tissue and an opaque container for storage, aiming to reduce contamination and distress.
Its introduction fundamentally alters the pathway away from surgical intervention. Currently, the NHS offers three main management options for miscarriage: expectant management (waiting for it to happen naturally), medical management (using medication to induce it), and surgical management.
Surgical procedures, such as Manual Vacuum Aspiration or an Evacuation of Retained Products of Conception under general anaesthetic, are required when other methods are unsuitable, incomplete, or in emergencies. These operations consume significant theatre time, bed space, and clinical manpower.
By providing a hygienic and effective means to collect tissue at home, the cradle can often preclude the need for these surgeries. Furthermore, it ensures collected tissue is preserved in a viable state. Dignity Care is collaborating with NHS laboratories to assess the quality of genetic samples obtained via the cradle compared to surgical collection, which could provide vital insights into the causes of miscarriage.
The rollout across multiple sites in NHS Greater Glasgow and Clyde, supported by £1.5 million in Scottish Government funding for compassionate miscarriage services, is the first of its scale in the UK. Patient testimonials gathered by the developers highlight the device’s role in offering choice and control during a deeply distressing experience, contrasting with previous experiences where women felt unprepared with only leaflets for guidance.
The broader economic and human impact
The independent health economic report underpins the significant financial rationale for the cradle’s adoption. The potential savings come from reduced surgical costs, freed clinical resources, and lower emergency admissions. This aligns with a broader context where miscarriage is estimated to cost the UK at least £471 million per year in direct health services and lost productivity, a figure some believe could exceed £1 billion when longer-term health impacts are considered.
The device also aligns with national care standards. The National Institute for Health and Care Excellence guidelines suggest natural management should be the first method considered for miscarriage and emphasise providing women with clear choices. For the approximately 5% of women who experience recurrent miscarriage, NICE advises GPs to refer for specialist care after three losses.
The psychological impact of pregnancy loss is profound, with increased risks of depression, anxiety, and suicide. A wide network of support organisations exists, including the Miscarriage Association, Tommy’s National Centre for Miscarriage Research, and Cruse Bereavement Care, alongside many groups offering culturally specific or specialised counselling.
Dignity Care, founded by former NHS engineer Laura Corcoran following her own personal experience, aims to see the cradle implemented across the wider NHS. The initiative represents a tangible shift towards care that prioritises both clinical efficiency and, fundamentally, the dignity of the patient.